StressCovidV1, France, Analysis, bibRecord, 000207

Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.

Identifieur interne : 000207 ( France/Analysis ); précédent : 000206; suivant : 000208

Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.

Auteurs : Xavier Duval [France] ; Adrian Caplanusi ; Henri Laurichesse ; Dominique Deplanque ; Pierre Loulergue ; Tejaswini Vaman ; Odile Launay ; Paul Gillard

Source :

BMC infectious diseases [ 1471-2334 ] ; 2012.

RBID : pubmed:22824474

Descripteurs français

KwdFr :
- Adjuvants immunologiques (administration et posologie), Adjuvants immunologiques (effets indésirables), Adolescent, Adulte, Adulte d'âge moyen, Anticorps antiviraux (sang), Calendrier vaccinal, Facteurs de l'âge, Facteurs temps, Femelle, Grippe humaine (), Humains, Jeune adulte, Mâle, Sous-type H1N1 du virus de la grippe A (immunologie), Tests d'inhibition de l'hémagglutination, Vaccination (), Vaccination (effets indésirables), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (effets indésirables), Vaccins antigrippaux (immunologie).
MESH :
- administration et posologie : Adjuvants immunologiques, Vaccins antigrippaux.
- effets indésirables : Adjuvants immunologiques, Vaccination, Vaccins antigrippaux.
- immunologie : Sous-type H1N1 du virus de la grippe A, Vaccins antigrippaux.
- sang : Anticorps antiviraux.
- Adolescent, Adulte, Adulte d'âge moyen, Calendrier vaccinal, Facteurs de l'âge, Facteurs temps, Femelle, Grippe humaine, Humains, Jeune adulte, Mâle, Tests d'inhibition de l'hémagglutination, Vaccination.

English descriptors

KwdEn :
- Adjuvants, Immunologic (administration & dosage), Adjuvants, Immunologic (adverse effects), Adolescent, Adult, Age Factors, Antibodies, Viral (blood), Female, Hemagglutination Inhibition Tests, Humans, Immunization Schedule, Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (adverse effects), Influenza Vaccines (immunology), Influenza, Human (prevention & control), Male, Middle Aged, Time Factors, Vaccination (adverse effects), Vaccination (methods), Young Adult.
MESH :
- chemical , administration & dosage : Adjuvants, Immunologic, Influenza Vaccines.
- chemical , adverse effects : Adjuvants, Immunologic, Influenza Vaccines.
- chemical , blood : Antibodies, Viral.
- adverse effects : Vaccination.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza Vaccines.
- methods : Vaccination.
- prevention & control : Influenza, Human.
- Adolescent, Adult, Age Factors, Female, Hemagglutination Inhibition Tests, Humans, Immunization Schedule, Male, Middle Aged, Time Factors, Young Adult.

Abstract

Flexibility of vaccination schedule and lower antigen content can facilitate pandemic vaccine coverage. We assessed the immune response and safety of AS03-adjuvanted A/California/7/2009 H1N1 pandemic vaccine containing half of the registered adult haemagglutinin (HA) antigen content, administered as a two-dose schedule at intervals of 21 days or 6 months in both young and elderly adults.

DOI: 10.1186/1471-2334-12-162
PubMed: 22824474

Affiliations:

France

Links to Exploration step

pubmed:22824474

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.</title>
<author><name sortKey="Duval, Xavier" sort="Duval, Xavier" uniqKey="Duval X" first="Xavier" last="Duval">Xavier Duval</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Paris Diderot, Sorbonne Paris Cité, Paris, UMR 738, France. xavier.duval@bch.aphp.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Diderot, Sorbonne Paris Cité, Paris, UMR 738</wicri:regionArea>
<wicri:noRegion>UMR 738</wicri:noRegion>
<wicri:noRegion>UMR 738</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Caplanusi, Adrian" sort="Caplanusi, Adrian" uniqKey="Caplanusi A" first="Adrian" last="Caplanusi">Adrian Caplanusi</name>
</author>
<author><name sortKey="Laurichesse, Henri" sort="Laurichesse, Henri" uniqKey="Laurichesse H" first="Henri" last="Laurichesse">Henri Laurichesse</name>
</author>
<author><name sortKey="Deplanque, Dominique" sort="Deplanque, Dominique" uniqKey="Deplanque D" first="Dominique" last="Deplanque">Dominique Deplanque</name>
</author>
<author><name sortKey="Loulergue, Pierre" sort="Loulergue, Pierre" uniqKey="Loulergue P" first="Pierre" last="Loulergue">Pierre Loulergue</name>
</author>
<author><name sortKey="Vaman, Tejaswini" sort="Vaman, Tejaswini" uniqKey="Vaman T" first="Tejaswini" last="Vaman">Tejaswini Vaman</name>
</author>
<author><name sortKey="Launay, Odile" sort="Launay, Odile" uniqKey="Launay O" first="Odile" last="Launay">Odile Launay</name>
</author>
<author><name sortKey="Gillard, Paul" sort="Gillard, Paul" uniqKey="Gillard P" first="Paul" last="Gillard">Paul Gillard</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22824474</idno>
<idno type="pmid">22824474</idno>
<idno type="doi">10.1186/1471-2334-12-162</idno>
<idno type="wicri:Area/PubMed/Corpus">000564</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000564</idno>
<idno type="wicri:Area/PubMed/Curation">000562</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000562</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000579</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000579</idno>
<idno type="wicri:Area/Ncbi/Merge">000531</idno>
<idno type="wicri:Area/Ncbi/Curation">000531</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000531</idno>
<idno type="wicri:Area/Main/Merge">001319</idno>
<idno type="wicri:Area/Main/Curation">001317</idno>
<idno type="wicri:Area/Main/Exploration">001317</idno>
<idno type="wicri:Area/France/Extraction">000207</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.</title>
<author><name sortKey="Duval, Xavier" sort="Duval, Xavier" uniqKey="Duval X" first="Xavier" last="Duval">Xavier Duval</name>
<affiliation wicri:level="1"><nlm:affiliation>Université Paris Diderot, Sorbonne Paris Cité, Paris, UMR 738, France. xavier.duval@bch.aphp.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris Diderot, Sorbonne Paris Cité, Paris, UMR 738</wicri:regionArea>
<wicri:noRegion>UMR 738</wicri:noRegion>
<wicri:noRegion>UMR 738</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Caplanusi, Adrian" sort="Caplanusi, Adrian" uniqKey="Caplanusi A" first="Adrian" last="Caplanusi">Adrian Caplanusi</name>
</author>
<author><name sortKey="Laurichesse, Henri" sort="Laurichesse, Henri" uniqKey="Laurichesse H" first="Henri" last="Laurichesse">Henri Laurichesse</name>
</author>
<author><name sortKey="Deplanque, Dominique" sort="Deplanque, Dominique" uniqKey="Deplanque D" first="Dominique" last="Deplanque">Dominique Deplanque</name>
</author>
<author><name sortKey="Loulergue, Pierre" sort="Loulergue, Pierre" uniqKey="Loulergue P" first="Pierre" last="Loulergue">Pierre Loulergue</name>
</author>
<author><name sortKey="Vaman, Tejaswini" sort="Vaman, Tejaswini" uniqKey="Vaman T" first="Tejaswini" last="Vaman">Tejaswini Vaman</name>
</author>
<author><name sortKey="Launay, Odile" sort="Launay, Odile" uniqKey="Launay O" first="Odile" last="Launay">Odile Launay</name>
</author>
<author><name sortKey="Gillard, Paul" sort="Gillard, Paul" uniqKey="Gillard P" first="Paul" last="Gillard">Paul Gillard</name>
</author>
</analytic>
<series><title level="j">BMC infectious diseases</title>
<idno type="eISSN">1471-2334</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjuvants, Immunologic (administration & dosage)</term>
<term>Adjuvants, Immunologic (adverse effects)</term>
<term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Antibodies, Viral (blood)</term>
<term>Female</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Humans</term>
<term>Immunization Schedule</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (adverse effects)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Time Factors</term>
<term>Vaccination (adverse effects)</term>
<term>Vaccination (methods)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adjuvants immunologiques (administration et posologie)</term>
<term>Adjuvants immunologiques (effets indésirables)</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Anticorps antiviraux (sang)</term>
<term>Calendrier vaccinal</term>
<term>Facteurs de l'âge</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Grippe humaine ()</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Vaccination ()</term>
<term>Vaccination (effets indésirables)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (effets indésirables)</term>
<term>Vaccins antigrippaux (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adjuvants, Immunologic</term>
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Adjuvants, Immunologic</term>
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Adjuvants immunologiques</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Adjuvants immunologiques</term>
<term>Vaccination</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Female</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Humans</term>
<term>Immunization Schedule</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Calendrier vaccinal</term>
<term>Facteurs de l'âge</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Vaccination</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Flexibility of vaccination schedule and lower antigen content can facilitate pandemic vaccine coverage. We assessed the immune response and safety of AS03-adjuvanted A/California/7/2009 H1N1 pandemic vaccine containing half of the registered adult haemagglutinin (HA) antigen content, administered as a two-dose schedule at intervals of 21 days or 6 months in both young and elderly adults.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><noCountry><name sortKey="Caplanusi, Adrian" sort="Caplanusi, Adrian" uniqKey="Caplanusi A" first="Adrian" last="Caplanusi">Adrian Caplanusi</name>
<name sortKey="Deplanque, Dominique" sort="Deplanque, Dominique" uniqKey="Deplanque D" first="Dominique" last="Deplanque">Dominique Deplanque</name>
<name sortKey="Gillard, Paul" sort="Gillard, Paul" uniqKey="Gillard P" first="Paul" last="Gillard">Paul Gillard</name>
<name sortKey="Launay, Odile" sort="Launay, Odile" uniqKey="Launay O" first="Odile" last="Launay">Odile Launay</name>
<name sortKey="Laurichesse, Henri" sort="Laurichesse, Henri" uniqKey="Laurichesse H" first="Henri" last="Laurichesse">Henri Laurichesse</name>
<name sortKey="Loulergue, Pierre" sort="Loulergue, Pierre" uniqKey="Loulergue P" first="Pierre" last="Loulergue">Pierre Loulergue</name>
<name sortKey="Vaman, Tejaswini" sort="Vaman, Tejaswini" uniqKey="Vaman T" first="Tejaswini" last="Vaman">Tejaswini Vaman</name>
</noCountry>
<country name="France"><noRegion><name sortKey="Duval, Xavier" sort="Duval, Xavier" uniqKey="Duval X" first="Xavier" last="Duval">Xavier Duval</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/France/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000207 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000207 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:22824474
   |texte=   Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:22824474" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021

Serveur d'exploration Stress et Covid

Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.

Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration Stress et Covid
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.